SNPs of the PSMA6 gene: Investigation of possible association with myocardial infarction and type 2 diabetes mellitus

Russian Journal of Genetics

Volumn 43, Issue 4, 2007, Pages 444-450

  Sjakste, T ^a   Poudziunas, I ^a   Ninio, E ^b   Perret, C ^b   Pirags, V ^a   Nicaud, V ^b   Lazdins, M ^a   Evans, A ^c   Morrison, C ^d   Cambien, F ^b   Sjakste, N ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b INSERM   (France)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247351999     PISSN: 10227954     EISSN: 16083369     Source Type: Journal    
DOI: 10.1134/S102279540704014X     Document Type: Article

References (33)

1. Almond, J.B. and Cohen, G.M., The Proteasome: A Novel Target for Cancer Chemotherapy, Leukemia, 2002, vol. 18, pp. 433-443.
2. Naujokat, C. and Hofman, S., Role and Function of the 26S Proteasome in Proliferation and Apoptosis, Lab. Invest., 2002, vol. 82, pp. 965-980.
3. Glickman, M. and Ciechanover, A., The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction, Physiol. Rev., 2001, vol. 82, pp. 373-428.
4. Sjakste, N., Sjakste, T., Rumba, I., and Vikmanis, U., Proteasomes in Pathology, Proc. Latv. Acad. Sci. B, 2002, vol. 56, nos. 1-2, pp. 7-16.
5. Sjakste, N., Sjakste, T., and Vikmanis, U., Role of the Ubiquitin-Proteasome Protein Degradation Pathway in Carcinogenesis, Tumor Progression and Susceptibility to Tumor Treatment, Exp. Oncol., 2002, vol. 24, pp. 243-248.
6. Bulteau, A.L., Lunbergs, K.C., Humphries, K.M., et al., Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion, J. Biol. Chem., 2001, vol. 276, no. 32, pp. 30057-30063.
7. Wilson, S.H., Simari, R.D., and Lerman, A., The Effect of Endothelin-1 on Nuclear Factor Kappa B in Macrophages, Biochem. Biophys. Res. Communs., 2001, vol. 286, pp. 968-972.
8. Vierira, O., Escargueil-Blanc, I., Jurgens, G., et al., LDLs alter the Activity of the Ubiquitin-Proteasome Pathway: Potential Role in Oxidezed LDL-Induced Apoptosis, FASEB J., 2000, vol. 14, no. 3, pp. 532-542.
9. Robbesyn, F., Garcia, V., Auge, N., et al., HDL Counter-balance the Proinflammatory Effect of Oxidized LDL by Inhibiting Intracellular Reactive Oxygen Species Rise, Proteasome Activation, and Subsequent NF-Kappa B Activation in Smooth Muscle Cells, FASEB J., 2003, vol. 17, no. 6, pp. 743-745.
10. Rome, S., Meugnier, E., and Vidal, H., The Ubiquitin-Proteasome Pathway is a New Partner for the Control of Insulin Signaling, Curr. Opin. Clin. Nutr. Metab. Care, 2004, vol. 7, no. 3, pp. 249-254.
11. Sjakste, T.G., Sjakste, N.I., and Scherrer, K., Exon/Intron Organisation of Pros-27 K Gene, DNA Sequence, 2001, vol. 12, no. 4, pp. 261-265.
12. Sjakste, T., Lauberte, L., Collan, Y., et al., Identification of an Intronic TG Repeat Polymorphism in the Human Proteasome Core Particle PROS-27K Gene, DNA Sequence, 2002, vol. 13, no. 3, pp. 139-144.
13. Sjakste, T., Eglite, E., Sochnev, A., et al., Microsatellite Genotyping of Chromosome 14q13.2-14q13 in the Area of Proteasomal PSMA6 Gene on Association with Graves' Disease in the Latvian Population, Immunogenetics, 2004, vol. 56, no. 4, pp. 238-243.
14. Kalis, M., Sjakste, T., Sjakste, N., et al., Association Study between (TG) Repeat Polymorphism in PSMA6 Gene and Type II Diabetes Mellitus in Bosnia, Biologija, 2002, vol. 2, pp. 12-14.
15. Parra, H.J., Arveiler, D., Evans, et al., A Case-Control Study of Lipoprotein Particles in Two Populations at Contrasting Risk for Coronary Heart Disease, ECTIM Study, Arterioscler. Thromb., 1992, vol. 12, pp. 701-707.
16. Tiret, L., Poirier, O., Nucaud, V., et al., Heterogeneity of Linkage Disequilibrium in Human Genes Has Implications for Association Studies of Common Diseases, Hum. Mol. Genet., 2002, vol. 11, pp. 419-429.
17. Tiret, L., Amouyerl, P., Rakotovao, R., et al., Testing for Association between Disease and Linked Marker Loci: A Log-Linear Model Analysis, Am. J. Hum. Genet., 1991, vol. 48, pp. 926-934.
18. Tregouet, D.A., Escolano, S., Tiret, et al., A New Algorithm for Haplotype-Based Association Analysis: The Stochastic-EM Algorithm, Ann. Hum. Genet., 2004, vol. 68, pp. 165-177.
19. Grossi de Sa, M.F., Martins de Sa, C., Harper, F., et al., The Association of Prosomes with Some of the Intermediate Filament Networks of the Animal Cell, J. Cell Biol., 1988, vol. 107, pp. 1517-1530.
20. Kozak, M., Emerging Links between Initiation of Translation and Human Diseases, Mammalian Genome, 2002, vol. 13, pp. 401-410.
21. Kozak, M., Pushing the Limits of the Scanning Mechanism for Initiation of Translation, Gene, 2002, vol. 299, pp. 1-34.
22. Kozak, M., Recognition of AUG and Alternative Initiator Codos Is Augmented by G in Position +4 but is not Generally Affected by the Nucleotides in Position +5 and +6, EMBO J., 1997, vol. 16, pp. 2482-2492.
23. + Channel by Nedd4 in Liddle's Syndrome, J. Clin. Invest., 1999, vol. 103, pp. 667-673.
24. Leitch, V., Agre, P., and King, L.S., Altered Ubiquitination and Stability of Aquaporin-1 in Hypertonie Stress, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 2894-2898.
25. Osawa, Y., Lowe, E.R., Everett, A.C., et al., Proteolytic Degradation of Nitric Oxide Synthase: Effect of Inhibitors and Role of hsp90-Based Chaperons, J. Pharmacol. Exp. Theor., 2003, vol. 304, no. 2, pp. 493-497.
26. Kolodziejski, P.J., Musial, A., Koo, J.S., and Eissa, N.T., Ubiquitination of Inducible Nitric Oxide Synthase Is Required for its Degradation, Proc. Natl Acad. Sci. USA, 2002, vol. 99, no. 19, pp. 12315-12320.
27. Musial, A. and Eissa, N.T., Inducible Nitric-Oxide Synthase is Regulated by the Proteasome Degradation Pathway, J. Biol. Chem., 2001, vol. 276, no. 26, pp. 24268-24273.
28. Ying, W.Z., Xia, H., and Sanders, P.W., Nitric Oxide Synthase (NOS2) Mutation in Dahl/Rapp Rats Decreases Enzyme Stability, Circ. Res., 2001, vol. 89, no. 4, pp. 317-322.
29. Ohkita, M., Takaoka, M., Kobayashi, et al., Involvement of Proteasome in Endothelin-1 production in Cultured Vascular Endothelial Cells, Jpn. J. Pharmacol., 2002, vol. 82, no. 2, pp. 197-205.
30. Horikawa, Y., Oda, N., Cox, N.J., et al., Genetic Variation in the Gene Encoding Calpain-10 is Associated with Type 2 Diabetes Mellitus, Nature Genet., 2000, vol. 26, pp. 63-75.
31. Johnson, J.D., Han, Z., Otani, K., et al., RyR2 and Calpain-10 Delineate a Novel Apoptosis Pathway in Pancreatic Islets, J. Biol. Chem., 2004, vol. 279, no. 23, pp. 24794-24802.
32. Zhou, Y.P., Sreenan, S., Pan, C.Y., et al., A 48-h Exposure of Pancreatic Islets to Calpain Inhibitors Impairs Mitochondrial Fuel Metabolism and the Exocytosis of Insulin, Metabolism, 2003, vol. 52, no. 2, pp. 528-534.
33. Ozaki, K., Sato, H., Iida, A., et al., A Functional SNP in PSMA6 Confers Risk of Myocardial Infarction in the Japanese Population, Nat. Genet., 2006, vol. 38, no. 8, pp. 921-925.